Brazil Threatens To Break Merck's Efavirenz Patent
Brazil on Wednesday reportedly threatened to break Merck & Co. Inc.'s patent on HIV/AIDS drug Efavirenz, warning it will tap into India's generic drug industry if the pharmaceutical giant will not...To view the full article, register now.
Already a subscriber? Click here to view full article